Cryo-Cell International Statistics
Share Statistics
Cryo-Cell International has 8.36M shares outstanding. The number of shares has increased by -2.72% in one year.
| Shares Outstanding | 8.36M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.53% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.83M |
| Failed to Deliver (FTD) Shares | 113 |
| FTD / Avg. Volume | 0.57% |
Short Selling Information
The latest short interest is 13.55K, so 0.17% of the outstanding shares have been sold short.
| Short Interest | 13.55K |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.35% |
| Short Ratio (days to cover) | 0.59 |
Valuation Ratios
The PE ratio is -4.69 and the forward PE ratio is 116.62.
| PE Ratio | -4.69 |
| Forward PE | 116.62 |
| PS Ratio | 1.42 |
| Forward PS | 1.9 |
| PB Ratio | -4.05 |
| P/FCF Ratio | 34.84 |
| PEG Ratio | n/a |
Enterprise Valuation
Cryo-Cell International Inc. has an Enterprise Value (EV) of 55.11M.
| EV / Earnings | -5.79 |
| EV / Sales | 1.76 |
| EV / EBITDA | -5.29 |
| EV / EBIT | -4.48 |
| EV / FCF | 43.03 |
Financial Position
The company has a current ratio of 0.45, with a Debt / Equity ratio of -0.89.
| Current Ratio | 0.45 |
| Quick Ratio | 0.42 |
| Debt / Equity | -0.89 |
| Total Debt / Capitalization | -809.55 |
| Cash Flow / Debt | 0.91 |
| Interest Coverage | -9.95 |
Financial Efficiency
Return on equity (ROE) is 0.86% and return on capital (ROIC) is 6483.73%.
| Return on Equity (ROE) | 0.86% |
| Return on Assets (ROA) | -0.16% |
| Return on Capital (ROIC) | 6483.73% |
| Revenue Per Employee | 382.24K |
| Profits Per Employee | -116.12K |
| Employee Count | 82 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 10.98 |
Taxes
| Income Tax | -3.84M |
| Effective Tax Rate | 0.29 |
Stock Price Statistics
The stock price has increased by 33.73% in the last 52 weeks. The beta is 0.51, so Cryo-Cell International 's price volatility has been higher than the market average.
| Beta | 0.51 |
| 52-Week Price Change | 33.73% |
| 50-Day Moving Average | 7.54 |
| 200-Day Moving Average | 7.4 |
| Relative Strength Index (RSI) | 43.9 |
| Average Volume (20 Days) | 19.84K |
Income Statement
In the last 12 months, Cryo-Cell International had revenue of $31.34M and earned -$9.52M in profits. Earnings per share was $-1.14.
| Revenue | 31.34M |
| Gross Profit | 22.90M |
| Operating Income | -12.30M |
| Net Income | -9.52M |
| EBITDA | -10.42M |
| EBIT | -12.30M |
| Earnings Per Share (EPS) | -1.14 |
Balance Sheet
The company has $406.07K in cash and $10.90M in debt, giving a net cash position of -$10.49M.
| Cash & Cash Equivalents | 406.07K |
| Total Debt | 10.90M |
| Net Cash | -10.49M |
| Retained Earnings | -31.16M |
| Total Assets | 62.93M |
| Working Capital | -6.76M |
Cash Flow
In the last 12 months, operating cash flow was $8.92M and capital expenditures -$7.64M, giving a free cash flow of $1.28M.
| Operating Cash Flow | 8.92M |
| Capital Expenditures | -7.64M |
| Free Cash Flow | 1.28M |
| FCF Per Share | 0.15 |
Margins
Gross margin is 73.07%, with operating and profit margins of -39.26% and -30.38%.
| Gross Margin | 73.07% |
| Operating Margin | -39.26% |
| Pretax Margin | -42.64% |
| Profit Margin | -30.38% |
| EBITDA Margin | -33.24% |
| EBIT Margin | -39.26% |
| FCF Margin | 4.09% |
Dividends & Yields
CCEL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -14.38% |
| FCF Yield | 1.93% |
Analyst Forecast
Currently there are no analyst rating for CCEL.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -0.36 |
| Piotroski F-Score | 7 |